Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2012
11/28/2012CN101365490B Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
11/28/2012CN101321517B Solid, orally administrable pharmaceutical drug delivery system with a fast release of the active substance
11/28/2012CN101233236B Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/28/2012CN101163507B Process for the preparation of polymer conjugates
11/28/2012CN101072588B Liposomes with improved drug retention for treatment of cancer
11/27/2012US8318917 Nucleic acids encoding antibodies having altered effector function and methods for making the same
11/27/2012US8318904 Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
11/27/2012US8318818 Topical composition, topical composition precursor, and methods for manufacturing and using
11/27/2012US8318817 Controlled release antimicrobial compositions and methods for the treatment of otic disorders
11/27/2012US8318816 Enhanced transport using membrane disruptive agents
11/27/2012US8318815 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
11/27/2012US8318797 Composition and methods for the protection of hair from treated pool water
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
11/27/2012US8318205 Polyethylene glycol/polycation block copolymers
11/27/2012US8318204 pH sensitive block copolymer and polymeric micelle using the same
11/27/2012US8318194 Implants for administering substances and methods of producing mesoporous implants
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012US8318171 Neurotoxic oligomers
11/27/2012US8318145 Multi-arm polymer prodrugs
11/27/2012CA2672902C Formulations
11/27/2012CA2608311C Glp-1 pegylated compounds
11/27/2012CA2601646C Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars
11/27/2012CA2599334C External plaster containing flurbiprofen
11/27/2012CA2573696C Liposome allowing liposome-entrapped substance to escape from endosome
11/27/2012CA2542663C Microemulsions of retinoids, and pharmaceutical compositions containing them
11/27/2012CA2513720C Method and apparatus for treating bodily tissues with medicinal substance
11/27/2012CA2481390C Nanoparticulate megestrol formulations
11/26/2012CA2778010A1 A novel blood substitute with complete red blood cell functions
11/23/2012DE202012009981U1 Maskierungskörper zur dosierten Verabreichung eines Arzneimittels Masking body for the dosed administration of a drug
11/22/2012WO2012159106A2 Ph responsive self-healing hydrogels formed by boronate-catechol complexation
11/22/2012WO2012158678A1 Methods for maintaining pegylation of polypeptides
11/22/2012WO2012158527A2 Organophosphorous & multivalent metal compound compositions & methods
11/22/2012WO2012158312A2 Skin and hair regeneration using polysaccharide-based hydrogels
11/22/2012WO2012157752A1 Pharmaceutical composition containing loxoprofen
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012156999A1 Ready to use docetaxel formulation
11/22/2012WO2012156979A1 A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
11/22/2012WO2012156920A1 Bio-orthogonal drug activation
11/22/2012WO2012156919A1 Bio-orthogonal drug activation
11/22/2012WO2012156918A1 Bio-orthogonal drug activation
11/22/2012WO2012156822A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration
11/22/2012WO2012156821A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
11/22/2012WO2012156820A1 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
11/22/2012WO2012156750A1 Hiv vaccine
11/22/2012WO2012156743A1 Therapeutic fusion proteins
11/22/2012WO2012156565A1 Injectable preparation of melatonin
11/22/2012WO2012156527A1 Pharmaceutical composition having improved bioavailability
11/22/2012WO2012156455A1 Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms
11/22/2012WO2012156452A1 Method for detecting infections
11/22/2012WO2012156376A1 Use of plant lectins to target leukocytes
11/22/2012WO2012156319A1 Novel anti-redness active agent and cosmetic compositions comprising same
11/22/2012WO2012156094A1 Nanoparticles functionalized with dendritic polyglycerol sulfate
11/22/2012WO2012156000A1 Method for separating a mixture of a protein and the reaction product thereof with a polyalkylene glycol
11/22/2012WO2012155920A1 Charge triggering of self-organized nanoparticles
11/22/2012WO2012155809A1 Edible liquid filled polysaccharide capsules
11/22/2012WO2012155780A1 Branched-peg modified glp-1 analogue and pharmaceutically acceptable salts thereof
11/22/2012WO2012155751A1 A method for preparing hbv vaccine comprising aluminum adjuvant
11/22/2012WO2012135010A3 Osmotic mediated release synthetic nanocarriers
11/22/2012WO2012108960A3 Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
11/22/2012WO2012106713A3 Targeted nanoparticle conjugates
11/22/2012WO2012059882A3 Engineered polypeptide conjugates and methods for making thereof using transglutaminase
11/22/2012WO2011124895A3 Phospholipid-containing pharmaceutical and nutraceutical compositions
11/22/2012WO2011123957A8 Biocompatible poly(amic acid) and method of preparation thereof
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295867 Method and pharmaceutical to treat spinal discs
11/22/2012US20120295848 Sustained-release composition and process for producing the same
11/22/2012US20120295833 Polysaccharides having an adjustable degree of functionalization
11/22/2012US20120295832 Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds
11/22/2012US20120294940 Rapidly disintegrating tablet in oral cavity
11/22/2012US20120294939 Direct compression formulation and process
11/22/2012US20120294934 Transdermal compositions for anticholinergic agents
11/22/2012US20120294928 Method of treating scars and b-catenin-mediated disorders using nefopam compounds
11/22/2012US20120294926 Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
11/22/2012US20120294907 Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
11/22/2012US20120294903 Methods and systems of making nanostructures
11/22/2012US20120294901 Novel cochleate formulations
11/22/2012US20120294893 Edible jelly-form composition, jelly-form preparation and method for producing jelly-form preparation
11/22/2012US20120294819 Novel polysiloxanes having quaternary ammonium groups, method for producing same and use thereof in formulations for cleansing and care
11/22/2012US20120292797 Solid pharmaceutical dispersions with enhanced bioavailability
11/22/2012DE102011101952A1 Mit dendritischem Polyglycerolsulfat funktionalisierte Nanopartikel With dendritic polyglycerol sulfate functionalized nanoparticles
11/22/2012CA2836574A1 Improved peptide pharmaceuticals for insulin resistance
11/22/2012CA2836573A1 Improved peptide pharmaceuticals
11/22/2012CA2836405A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration
11/22/2012CA2836398A1 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
11/22/2012CA2836365A1 Bio-orthogonal drug activation
11/22/2012CA2836361A1 Bio-orthogonal drug activation
11/22/2012CA2836338A1 Bio-orthogonal drug activation
11/22/2012CA2836317A1 Charge triggering of self-organized nanoparticles
11/22/2012CA2836273A1 Thermostable vaccine compositions and methods of preparing same
11/22/2012CA2835911A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
11/22/2012CA2835882A1 Compositions and methods for the alteration of xlhed phenotypes
11/22/2012CA2835738A1 Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms
11/22/2012CA2835285A1 Therapeutic fusion proteins
11/22/2012CA2834813A1 Skin and hair regeneration using polysaccharide-based hydrogels
11/22/2012CA2820845A1 A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
11/21/2012EP2524929A1 Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
11/21/2012EP2524701A2 Pharmaceutical composition and method for producing the same
11/21/2012EP2524698A1 Insulin preparation
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1712